Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (391-400 of 533) with videos related to

Pageof 54
Sort By:
Dermatology Practical & Conceptual|August 9, 2024
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio RegionAnnunziata Dattola, Nicoletta Bernardini, Giacomo Caldarola, et al.
Clinical and Experimental Dermatology|September 27, 2023
Lentigo maligna and lentigo maligna melanoma in patients younger than 50 years: a multicentre international clinical-dermoscopic studyCaterina Longo, Alberto Sticchi, Alex Curti, et al.
Journal of Clinical Medicine|July 27, 2022
Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis SuppurativaLuca Fania, Giulia Giovanardi, Tonia Samela, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 15, 2018
Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelinesKetty Peris, Mauro Alaibac, Giuseppe Argenziano, et al.
JAMA Dermatology|October 1, 2020
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialKristian Reich, Kenji Kabashima, Ketty Peris, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 14, 2020
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patientsClara De Simone, Laura Calabrese, Anna Balato, et al.
Journal of Personalized Medicine|July 27, 2022
ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face CancerLuca Tagliaferri, Ilaria Giarrizzo, Bruno Fionda, et al.
Dermatology and Therapy|February 5, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTENDAndrew Blauvelt, H Chih-Ho Hong, Norito Katoh, et al.
The Journal of Investigative Dermatology|March 28, 2008
MC1R variants increase risk of melanomas harboring BRAF mutationsMaria Concetta Fargnoli, Maria Concetia Fargnoli, Kris Pike, et al.
Human Vaccines & Immunotherapeutics|July 15, 2020
Efficacy of immune checkpoint inhibitors in different types of melanomaErnesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.
Pageof 54

Showing results (391-400 of 533) with videos related to

Sort By:
Pageof 54
Dermatology Practical & Conceptual|August 9, 2024
Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio RegionAnnunziata Dattola, Nicoletta Bernardini, Giacomo Caldarola, et al.
Clinical and Experimental Dermatology|September 27, 2023
Lentigo maligna and lentigo maligna melanoma in patients younger than 50 years: a multicentre international clinical-dermoscopic studyCaterina Longo, Alberto Sticchi, Alex Curti, et al.
Journal of Clinical Medicine|July 27, 2022
Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis SuppurativaLuca Fania, Giulia Giovanardi, Tonia Samela, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 15, 2018
Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelinesKetty Peris, Mauro Alaibac, Giuseppe Argenziano, et al.
JAMA Dermatology|October 1, 2020
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialKristian Reich, Kenji Kabashima, Ketty Peris, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 14, 2020
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patientsClara De Simone, Laura Calabrese, Anna Balato, et al.
Journal of Personalized Medicine|July 27, 2022
ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face CancerLuca Tagliaferri, Ilaria Giarrizzo, Bruno Fionda, et al.
Dermatology and Therapy|February 5, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTENDAndrew Blauvelt, H Chih-Ho Hong, Norito Katoh, et al.
The Journal of Investigative Dermatology|March 28, 2008
MC1R variants increase risk of melanomas harboring BRAF mutationsMaria Concetta Fargnoli, Maria Concetia Fargnoli, Kris Pike, et al.
Human Vaccines & Immunotherapeutics|July 15, 2020
Efficacy of immune checkpoint inhibitors in different types of melanomaErnesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.
Pageof 54